| Genomic Medicine |
1 |
1 |
| Lung Cancer |
0 |
1 |
| Breast Cancer |
0 |
0.95 |
| Hepatocellular Carcinoma |
0 |
0.85 |
| Tumor |
0 |
0.82 |
| Skin Cancer |
0 |
0.59 |
| Ovarian Cancer |
0 |
0.52 |
| Colorectal Cancer |
0 |
0.51 |
| Prostate Cancer |
0 |
0.51 |
| Biologic Therapy |
0 |
0.5 |
| Pancreatic Cancer |
0 |
0.47 |
| Palliative Care |
0 |
0.43 |
| Tissue |
0 |
0.3 |
| Biopsy |
0 |
0.24 |
| Metastasis |
0 |
0.24 |
| Somatic |
0 |
0.24 |
| Cancer |
0 |
0.23 |
| Non-Small Cell Lung Cancer |
0 |
0.21 |
| Hereditary Nonpolyposis Colorectal Cancer (HNPCC) |
0 |
0.19 |
| Small Cell Lung Cancer |
0 |
0.18 |
| Advanced Cancer |
0 |
0.17 |
| Cancer Risk |
0 |
0.17 |
| Colon Cancer |
0 |
0.17 |
| Targeted Cancer Therapy |
0 |
0.17 |
| Muscle Biopsy |
0 |
0.15 |
| Epidermal Growth Factor Receptor |
0 |
0.14 |
| Genetics |
0 |
0.1 |
| Lung |
0 |
0.07 |
| Melanoma |
0 |
0.06 |
| Prostate |
0 |
0.06 |
| Biomarker |
0 |
0.05 |
| Blood |
0 |
0.05 |
| Clinical Guidelines |
0 |
0.05 |
| Myelodysplastic Syndrome |
0 |
0.05 |
| Blood Vessel |
0 |
0.04 |
| Board Certification |
0 |
0.04 |
| Chronic Lymphocytic Leukemia |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Microsatellite Instability |
0 |
0.04 |
| Medical Life |
0 |
0.03 |
| Microsatellite Instability-High |
0 |
0.03 |
| Stem Cell Research and Therapy |
0 |
0.03 |
| Tyrosine Kinase Inhibitor |
0 |
0.03 |
| Bone |
0 |
0.02 |
| BRCA |
0 |
0.02 |
| DNA Sequencing |
0 |
0.02 |
| Hematologic Malignancies |
0 |
0.02 |
| Liver |
0 |
0.02 |
| Receptors |
0 |
0.02 |
| Tyrosine Kinase |
0 |
0.02 |
| Adenocarcinoma |
0 |
0.01 |
| Anticoagulation Therapy |
0 |
0.01 |
| Appendix |
0 |
0.01 |
| BRAF |
0 |
0.01 |
| Breast |
0 |
0.01 |
| Chemotherapy |
0 |
0.01 |
| Hand |
0 |
0.01 |
| Histology |
0 |
0.01 |
| Interference |
0 |
0.01 |
| Leukemia |
0 |
0.01 |
| Lymph Node |
0 |
0.01 |
| Match |
0 |
0.01 |
| Medical Oncology |
0 |
0.01 |
| Muscle |
0 |
0.01 |
| Platinum |
0 |
0.01 |
| Poly ADP-Ribose Polymerase (PARP) Inhibitor |
0 |
0.01 |
| Psychosocial |
0 |
0.01 |
| Referral |
0 |
0.01 |
| Resection |
0 |
0.01 |
| Small Molecule Inhibitor |
0 |
0.01 |